|
1
|
Friedman SL, Neuschwander-Tetri BA, Rinella M and Sanyal AJ: Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 24:908–922. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eslam M, Valenti L and Romeo S: Genetics and epigenetics of NAFLD and NASH: Clinical impact. J Hepatol. 68:268–279. 2018. View Article : Google Scholar
|
|
3
|
Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, O'Dea K, Desmond PV, Johnson NA and Wilson AM: The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 59:138–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baur JA and Sinclair DA: Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov. 5:493–506. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Faghihzadeh F, Adibi P, Rafiei R and Hekmatdoost A: Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 34:837–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tejada S, Capó X, Mascaró CM, Monserrat-Mesquida M, Quetglas-Llabrés MM, Pons A, Tur JA and Sureda A: Hepatoprotective effects of resveratrol in non-alcoholic fatty live disease. Curr Pharm Des. 27:2558–2570. 2021. View Article : Google Scholar
|
|
7
|
Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Du J, Niu X, Fu N, Wang R, Zhang Y, Zhao S, Sun D and Nan Y: MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. Cell Death Dis. 8:e27922017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du J, Niu X, Wang Y, Kong L, Wang R, Zhang Y, Zhao S and Nan Y: MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a. Sci Rep. 5:161632015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang DP, Tang XZ, Liang QK, Zeng XJ, Yang JB and Xu J: MicroRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via down-regulation of Hey2-depentent Notch signaling pathway. J Cell Physiol. 235:2492–2505. 2020. View Article : Google Scholar
|
|
11
|
Zhou JL, Deng S, Fang HS, Du XJ, Peng H and Hu QJ: Circular RNA circANKRD36 regulates Casz1 by targeting miR-599 to prevent osteoarthritis chondrocyte apoptosis and inflammation. J Cell Mol Med. 25:120–131. 2021. View Article : Google Scholar
|
|
12
|
Schwabe RF and Luedde T: Apoptosis and necroptosis in the liver: A matter of life and death. Nat Rev Gastroenterol Hepatol Dec. 15:738–752. 2018. View Article : Google Scholar
|
|
13
|
Okamura M, Shizu R, Abe T, Kodama S, Hosaka T, Sasaki T and Yoshinari K: PXR functionally interacts with NF-κB and AP-1 to downregulate the inflammation-induced expression of chemokine CXCL2 in mice. Cells. 9:E22962020. View Article : Google Scholar
|
|
14
|
Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W and Tian Y: Role of NF-kappaB in regulation of PXR-mediated gene expression: A mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem. 281:17882–17889. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du J, Niu X, Wang R, Zhao S, Kong L, Zhang Y and Nan Y: TLR4-dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in mice. Mol Med Rep. 13:2159–2166. 2016. View Article : Google Scholar
|
|
16
|
Li S, Zheng X, Zhang X, Yu H, Han B, Lv Y, Liu Y, Wang X and Zhang Z: Exploring the liver fibrosis induced by deltamethrin exposure in quails and elucidating the protective mechanism of resveratrol. Ecotoxicol Environ Saf. 207:1115012021. View Article : Google Scholar
|
|
17
|
Lv Y, Bing Q, Lv Z, Xue J, Li S, Han B, Yang Q, Wang X and Zhang Z: Imidacloprid-induced liver fibrosis in quails via activation of the TGF-β1/Smad pathway. Sci Total Environ. 705:1359152020. View Article : Google Scholar
|
|
18
|
Han B, Wang X, Wu P, Jiang H, Yang Q, Li S, Li J and Zhang Z: Pulmonary inflammatory and fibrogenic response induced by graphitized multi-walled carbon nanotube involved in cGAS-STING signaling pathway. J Hazard Mater. 417:1259842021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA and Bacon BR: Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol. 94:2467–2474. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC and Torbenson MS: Unalp-Arida A, et al Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41. pp. 1313–1321. 2005, View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
22
|
Zanieri F, Levi A, Montefusco D, Longato L, De Chiara F, Frenguelli L, Omenetti S, Andreola F, Luong TV, Massey V, et al: Exogenous liposomal ceramide-C6 ameliorates lipidomic profile, energy homeostasis, and anti-oxidant systems in NASH. Cells. 9:12372020. View Article : Google Scholar :
|
|
23
|
Pilling D, Karhadkar TR and Gomer RH: A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet. PLoS One. 15:e02447622020. View Article : Google Scholar
|
|
24
|
Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al: Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444. pp. 337–342. 2006, View Article : Google Scholar
|
|
25
|
Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, et al: AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13:376–388. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shang J, Chen LL, Xiao FX, Sun H, Ding HC and Xiao H: Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol Sin. 29:698–706. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ and Yu J: Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice. Scand J Gastroenterol. 46:358–369. 2011. View Article : Google Scholar
|
|
28
|
Hu G, Xu C and Staudinger JL: Pregnane X receptor is SUMOylated to repress the inflammatory response. J Pharmacol Exp Ther. 335:342–350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mencarelli A, Renga B, Palladino G, Claudio D, Ricci P, Distrutti E, Barbanti M, Baldelli F and Fiorucci S: Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells. Eur J Pharmacol. 668:317–324. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou C, Tabb MM, Nelson EL, Grün F, Verma S, Sadatrafiei A, Lin M, Mallick S, Forman BM, Thummel KE and Blumberg B: Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Investig. 116. pp. 2280–2289. 2006, View Article : Google Scholar
|
|
31
|
Huang K, Mukherjee S, DesMarais V, Albanese JM, Rafti E, Draghi Ii A, Maher LA, Khanna KM, Mani S and Matson AP: Targeting the PXR-TLR4 signaling pathway to reduce intestinal inflammation in an experimental model of necrotizing enterocolitis. Pediatr Res. 83:1031–1040. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Jiang H, Wu P, Li S, Han B, Yang Q, Wang X, Han B, Deng N, Qu B and Zhang Z: Toxicological effects of deltamethrin on quail cerebrum: Weakened antioxidant defense and enhanced apoptosis. Environ Pollut. 286:1173192021. View Article : Google Scholar
|
|
33
|
Hess J, Angel P and Schorpp-Kistner M: AP-1 subunits: Quarrel and harmony among siblings. J Cell Sci. 117:5965–5973. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wree A, McGeough MD, Inzaugarat ME, Eguchi A, Schuster S, Johnson CD, Peña CA, Geisler LJ, Papouchado BG, Hoffman HM and Feldstein AE: NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice. Hepatology. 67:736–749. 2018. View Article : Google Scholar
|
|
35
|
Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, et al: NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol. 66:1037–1046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Masters SL: Specific inflammasomes in complex diseases. Clin Immunol. 147:223–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schroder K and Tschopp J: The inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ouyang X, Ghani A and Mehal WZ: Inflammasome biology in fibrogenesis. Biochim Biophys Acta. 1832:979–988. 2013. View Article : Google Scholar
|
|
39
|
Rose-John S, Scheller J, Elson G and Jones SA: Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer. J Leukoc Biol. 80:227–236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Grivennikov S and Karin M: Autocrine IL-6 signaling: A key event in tumorigenesis? Cancer Cell. 13:7–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Imajo K, Fujita K, Yoneda M, Nozaki Y, Ogawa Y, Shinohara Y, Kato S, Mawatari H, Shibata W, Kitani H, et al: Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab. 16:44–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kessoku T, Imajo K, Honda Y, Kato T, Ogawa Y, Tomeno W, Kato S, Mawatari H, Fujita K, Yoneda M, et al: Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis. Sci Rep. 6:222512016. View Article : Google Scholar :
|
